Filing Details
- Accession Number:
- 0001127602-10-015089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-21 13:00:00
- Reporting Period:
- 2010-05-19
- Filing Date:
- 2010-05-21
- Accepted Time:
- 2010-05-21 15:15:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874663 | Alkermes Inc | ALKS | Pharmaceutical Preparations (2834) | 232472830 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181171 | W David Anstice | 852 Winter St. Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-19 | 5,000 | $11.35 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Average purchase price. The range of purchase prices was $11.32 to $11.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
